Mark Fleischhauer
Known title: DirectorCIK: 0002036507
Mark Fleischhauer's purchase track record
Mark Fleischhauer has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/5/2024 | ATEX | $120K | +13.4% | -20.2% | -2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ATEX | ▲ Buy | Grant | 1,598 | $0 | 8/4/2026 | View on chart |
| ATEX | ▼ Sell | Open Market | 3,500 | $279K | 6/15/2026 | View on chart |
| ATEX | ▲ Buy | Grant | 7,767 | $0 | 8/5/2025 | View on chart |
| ATEX | ▲ Buy | Open Market | 3,500 | $120K | 12/5/2024 | View on chart |
| ATEX | ▲ Buy | Grant | 5,002 | $0 | 12/5/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
ATEX spectrum outlook shifts after SpaceX $8B deal
SpaceX announced an $8 billion agreement to acquire low‑band spectrum, which analysts say could raise the market value of similar holdings. Anterix, which owns low‑band spectrum, is being discussed as potentially undervalued by about 6 % while questions remain about how it will monetize the assets. The combination of the deal and valuation debate may influence investor perception of Anterix’s spectrum position.
ATEX spectrum outlook shifts after SpaceX $8B deal. SpaceX announced an $8 billion agreement to acquire low‑band spectrum, which analysts say could raise the market value of similar holdings. Anterix, which owns low‑band spectrum, is being discussed as potentially undervalued by about 6 % while questions remain about how it will monetize the assets. The combination of the deal and valuation debate may influence investor perception of Anterix’s spectrum position.